Education

(Most of the documents on the NIPC website require Adobe Acrobat Reader to view...click here to download FREE Acrobat Reader)

• Purdue (OxyContin) Races Rivals to Deter Abuse
  
  
• Study Warns Job Losses Will Impact Government Health Programs
  
  
• 28% of Children Not Getting Recommended Vaccines
  
  
• Risk of Depression with new Anti-Addiction Drugs
  
  
• Cimzia Approved for Crohn's Disease
  
  
• Vyvanse Approved for Adult ADHD
  
  
• Disposal of Prescription Drugs
  
  
• Apple a Day Keeps the Doctor Away?
  
  
• Infant Heart Defects Tied to Maternal Smoking
  
  
• Abdominal Fat Linked to Dementia
  
  
• State-by-State Comparison of Healthcare Quality (AHRQ)
  
  
• Study Shows Prescription Drug Abuse in Colleges
  
  
• More Expensive Placebos Bring More Relief
  
  
• Federal Panel Recommends all Kids get Flu Shots
  
  
• Study Questions Effectiveness of Antidepressants
  
  
• Antibiotics Do Little for Inner Ear Infections?
  
  
• Rx Drugs Sales Rates Hits 47-Year Low
  
  
• News from the FDA:
  Pristiq (desvenlafaxine) Approved;
  Dextroamphetamine Solution Approved;
  Tussionex Alert Issued;
  Arcalyst Approved;
  Nexium Age 1-11 Approved;
  Simcor (niacin/simvastatin) Approved;
  Xyzal (levocetirizine dihydrochloride) Approved for Allergies;
  Off-Label Marketing Guidelines Proposed;
  New OTC Medicine Labels
  
  
• Cholesterol-lowering Drugs May Hold Hidden Benefits for Heart Patients
  
  
• JAMA Report - High Costs Associated with Back and Neck Pain
  
  
• Botox and Myobloc Side Effects Prompt Warnings
  
  
• FDA Approves Schering-Plough's New Pediatric Inhaler for Asthma - Asmanex
  
  
• Aspirin May Reduce Risk of Colon Cancer
  
  
• FDA Approves Generic Fosamax
  
  
• FDA Issues Chantix Warning
  
  
• FDA --- Epilepsy Drugs May Raise Suicide Risk
  
  
• Confusing Medication Names Addressed
  
  
• Cranberries and Urinary Tract Infections
  
  
• Birth Control Pill Might Lower Ovarian Cancer Risk
  
  
• Cold Drugs Send Kids to the ER
  
  
• Pharmacist Shortage in Ohio
  
  
• Diuretics the Best Treatment?
  
  
• Study Compares Vytorin against Zocor
  
  
• Almost One-Third of all adults in U.S. are Hypertensive
  
  
• Preventing Adverse Drug Events in Seniors
  
  
• FDA Declines OTC Status for Mevacor
  
  
• Lowering Copays Helps Treatment of Chronic Diseases?
  
  
• Statins May Cut Cancer Risk
  
  
• Symlin Pen Now Available
  
  
• FDA Approves Once-Daily Cialis
  
  
• Osteoporosis Meds and the Prevention of Fractures - Any Difference?
  
  
• Pain Treatment for Blacks/Hispanics in the ER
  
  
• OTC Cold Survey
  
  
• Suit Filed Over Generic Crestor
  
  
• Zetia Trial Scrutinized
  
  
• Schering Offers Free Continuing Education - Hepatitis C
  
  
• Schering Offers Allergic Rhinitis CE - Free
  
  
• APhA Offers Last Minute CE Connection
  
  
• PBM Laws by State
  
  
• New Tamiflu Warnings
  
  
• Kaiser Report - (November 2007) State Fiscal Conditions and Medicaid
  
  
• FDA Warns Prescribers about Anti-Anemia Drugs
  
  
• FDA Approves OTC Zyrtec
  
  
• FDA Approves Abilify for use in Adolescents
  
  
• NIPC Board Member, Dr. Richard Logan, Works with Scott County Task Force to Combat Prescription Drug Abuse
  
  
• Self-Monitoring of Blood Glucose - CE
  
  
• Myocardial Infarction Defined
  
  
• Medicaid's Role in Family Planning
  
  
• Pain Management in Nursing Homes
  
  
• Cultural Diversity and Medication Errors
  
  
• FDA Approves First Version of Generic Trileptal
  
  
• FDA Approves Additional Flu Vaccine
  
  
• Number of Uninsured Vets Nears 2 Million
  
  
• Medicare Drug Plans by State for 2008
  
  
• Hepatitis C: Practical Strategies to Minimize the Clinical and Economical Burden - Free CE from Schering Plough
  
  
• FDA Considers Third Drug Category
  
  
• Program Gives Pharmacists More Clout in Patient Care
  
  
• "The Link" - Pharmacy Critical Information from AmerisourceBergen
  
  
• FDA Approves More Generic Drugs
  
  
• Do Out-of-Pocket Costs Put Necessary Care "On Hold"?
  
  
• National Asthma Guidelines Updated
  
  
• Medication Nonadherence and Cardiovascular Risk Factors
  
  
• Health Care Quality Increases, but so do Costs
  
  
• Obesity: Which Drug and When?
  
  
• Lipitor Tops Best-Selling Brand Name Drugs
  
  
• Generic Coreg is Approved by FDA
  
  
• Do Side Effects Impact Breast Cancer Treatments?
  
  
• Consensus Statement Issued on Worldwide Standardization of HbA1c Measurement
  
  
• Cancer Society Focuses its Ads on the Uninsured
  
  
• Generic Manufacturers' Profits Should Increase
  
  
• Oral Antidiabetic Agents in Pregnancy and Lactation
  
  
• New FDA Approval for Risperdal (for more info click here)
  
  
• New FDA Approval for Zingo (for more info click here)
  
  
• New FDA Approval for Reclast (for more info click here)
  
  
• New Information about Caduet (please be patient as it may take a few seconds to download this file)
  
  
• Bariatric Surgery Found to Cut Risks
  
  
• Guide to CMS Patient Mailings Regarding Medicare
  
  
• National Study to Determine the Cost of Dispensing Prescriptions in Community Retail Pharmacies
  January 2007
  Grant Thornton LLP
  
  
• Medicare Part D Drug Benefit Progress Report
  
  
• Medicare Drugs Too Costly for Many
  
  
• Novo Diabetes Treatment Reduces Blood Sugar and Weight
  
  
• FDA Takes Caution on Approving New Drugs
  
  
• Kaiser Family Foundation Online Medicaid Benefit Database
  
  
• "Your Guide to Medicare Prescription Drug Coverage"
  
  
• Diabetes Drug Warnings Strengthened
  
  
• Furosemide Resistance in Heart Failure Patients
  
  
• FDA Limits Children's Cough and Cold Medicines
  
  
• FDA Approves New Strength of Stalevo
  
  
• Millions not taking prescribed drugs correctly, study shows
  
  
• Citalopram Treatment Success Predicted by Genes?
  
  
• Gene Predicts Better Outcome with ADHA
  
  
• FDA Approves Novel Antiretroviral Drug
  
  
• Vyvanse now available for ADHD treatment
  
  
• Generics Slow Rise in Drug Prices
  
  
• Current Issues in Heparin Dosing
  
  
• Help Your Patients Make a Smooth Transition to HFA Albuterol Inhalers
  
  
• Study Finds Older Diabetes Drugs Safer, Cheaper
  
  
• Did Tougher Eligibility Requirements for Illegal Immigrants Affect Medicaid Enrollment? The GAO Reports
  
  
• ACE Inhibitors, ARBs Improve Survival
  
  
• Exelon Patch Approved
  
  
• Health Care Costs and Their Impact - A Report from the Kaiser Family Foundation
  
  
• Medicaid Pharmacy Reimbursement and Services for all states (Kaiser Family Foundation)
  
  
• Schering-Plough Offers Free CE Support for Asthma Treatment Guidelines and the Use of Inhalers and Serious Fungal Infections: New Strategies to Optimize Treatment Outcomes
  
  
• One Soft Drink Daily May Boost Heart Disease
  
  
• Chronically Ill Adults Wait for Medicare Coverage
  
  
• The End of AWP?
  
  
• HealthCast 2020: Creating a Sustainable Future - Price WaterHouseCoopers
  
  
• APhA and NACDS to Showcase MTM at Conference
  
  
• Generic Plavix Blocked
  
  
• Examination of State-Level Changes in the Pharmacist Labor Market Using Census Data
  
  
• Medication and Alcohol Misuse Among Older Adults
  
  
• FDA sets deadline for unapproved cough/cold remedies
  
  
• CDC Report on Ambulatory Care
  
  
• Nicotine Patch Demonstrated to be Safe in Smokers with CAD
  
  
• ACPE Approved Pharmacy Continuing Education (CE)
  
  
• Top 10 Drug Firms by Prescription Sales Volume and Dollars